Finding 627107 (2022-001)

Significant Deficiency
Requirement
C
Questioned Costs
$1
Year
2022
Accepted
2023-10-01
Audit: 48407
Auditor: Crowe LLP

AI Summary

  • Core Issue: The Corporation delayed payments to contractors by 16 days after receiving federal funds, leading to a significant deficiency in cash management controls.
  • Impacted Requirements: Compliance with Title 2 U.S. CFR Part 200, which mandates timely disbursement of federal funds for intended purposes.
  • Recommended Follow-Up: Assign a dedicated individual to monitor federal fund receipts and ensure prompt disbursement, while also verifying the accuracy of draw amounts.

Finding Text

Finding 2022-001 - Controls Over Cash Management (Significant Deficiency) Criteria: According to Title 2 U.S. Code of Federal Regulations (?CFR?) Part 200, paragraph 305, non-federal entities are required to minimize the time that elapses between the transfer of funds from the federal funding source and the disbursement of those funds by the non-federal entity for the program?s intended purposes. Condition and Context: As a part of our testing over cash management of funds received from the federal funding source, we examined information showing the dates on which five program-related disbursement of federal funds were received by the Corporation, and we compared those dates to the dates when the Corporation remitted the amounts for the purposes of covering payroll expenses and paying its various contractors. We noted one draw for $1,184,367 that was received from the federal funding source with no payments made to the contractors for which the funds had been appropriated. This resulted in a period of 16 days between receipt of the federal funds and the corresponding payments to the contractors. We also noted one of the five draws tested were for an incorrect amount. The Corporation submitted a draw for $29,997 in error. The overdrawn funds were repaid to the federal funding source. The Corporation prepared a schedule of draws made during 2022 and it was noted that the Corporation drew or repaid an incorrect amount in four months of the year, of which some were corrected in the next period. Effect: As a result of these matters, the Corporation essentially borrowed money from the federal government and delayed payment to vendors. Cause: The condition was caused by an oversight by management that resulted in invoices not being processed for payment until well after the cash had been drawn by the Corporation and resulted in draws to processed for an incorrect amount. Questioned Costs: From our sample tests, the Corporation overdrew $29,997 for the month of May 2022. Recommendation: We recommend that management designate a specific individual to be responsible for monitoring the receipt of federal funds on a daily basis. This person should be tasked with ensuring that funds that have been transferred from the federal funding source are disbursed to the intended contractors within a short period following receipt of these funds and ensuring that the correct draw amounts are submitted. We also recommend that management prepare a schedule of all claims to determine whether there are additional amounts that have been overclaimed. Views of responsible officials and planned corrective actions: Management agrees with the finding and has prepared a corrective action plan.

Categories

Questioned Costs Subrecipient Monitoring Cash Management Significant Deficiency Matching / Level of Effort / Earmarking Internal Control / Segregation of Duties

Other Findings in this Audit

  • 50665 2022-001
    Significant Deficiency
  • 50666 2022-002
    Material Weakness
  • 50667 2022-001
    Significant Deficiency
  • 50668 2022-002
    Material Weakness
  • 50669 2022-001
    Significant Deficiency
  • 50670 2022-002
    Material Weakness
  • 50671 2022-001
    Significant Deficiency
  • 50672 2022-002
    Material Weakness
  • 50673 2022-001
    Significant Deficiency
  • 50674 2022-002
    Material Weakness
  • 50675 2022-001
    Significant Deficiency
  • 50676 2022-002
    Material Weakness
  • 50677 2022-001
    Significant Deficiency
  • 50678 2022-002
    Material Weakness
  • 50679 2022-001
    Significant Deficiency
  • 50680 2022-002
    Material Weakness
  • 50681 2022-001
    Significant Deficiency
  • 50682 2022-002
    Material Weakness
  • 50683 2022-001
    Significant Deficiency
  • 50684 2022-002
    Material Weakness
  • 627108 2022-002
    Material Weakness
  • 627109 2022-001
    Significant Deficiency
  • 627110 2022-002
    Material Weakness
  • 627111 2022-001
    Significant Deficiency
  • 627112 2022-002
    Material Weakness
  • 627113 2022-001
    Significant Deficiency
  • 627114 2022-002
    Material Weakness
  • 627115 2022-001
    Significant Deficiency
  • 627116 2022-002
    Material Weakness
  • 627117 2022-001
    Significant Deficiency
  • 627118 2022-002
    Material Weakness
  • 627119 2022-001
    Significant Deficiency
  • 627120 2022-002
    Material Weakness
  • 627121 2022-001
    Significant Deficiency
  • 627122 2022-002
    Material Weakness
  • 627123 2022-001
    Significant Deficiency
  • 627124 2022-002
    Material Weakness
  • 627125 2022-001
    Significant Deficiency
  • 627126 2022-002
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
20.507 Covid-19 - Federal Transit_formula Grants $583,709
20.507 Federal Transit_formula Grants $107,342